Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis.
Stabile A, Mazzone E, Cirulli GO, De Cobelli F, Grummet J, Thoeny HC, Emberton M, Pokorny M, Pinto PA, Taneja SS. Stabile A, et al. Among authors: cirulli go. Eur Urol Oncol. 2021 Aug;4(4):519-528. doi: 10.1016/j.euo.2020.11.008. Epub 2020 Dec 28. Eur Urol Oncol. 2021. PMID: 33384275 Review.
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Mazzone E, Stabile A, Pellegrino F, Basile G, Cignoli D, Cirulli GO, Sorce G, Barletta F, Scuderi S, Bravi CA, Cucchiara V, Fossati N, Gandaglia G, Montorsi F, Briganti A. Mazzone E, et al. Among authors: cirulli go. Eur Urol Oncol. 2021 Oct;4(5):697-713. doi: 10.1016/j.euo.2020.12.004. Epub 2020 Dec 25. Eur Urol Oncol. 2021. PMID: 33358543 Review.
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era?
Mazzone E, Stabile A, Sorce G, Pellegrino F, Barletta F, Motterle G, Scuderi S, Cirulli GO, Cucchiara V, Brembilla G, Esposito A, Gandaglia G, Fossati N, De Cobelli F, Montorsi F, Karnes RJ, Guccini I, Briganti A. Mazzone E, et al. Among authors: cirulli go. Urol Oncol. 2021 Nov;39(11):784.e1-784.e9. doi: 10.1016/j.urolonc.2021.03.013. Epub 2021 Apr 15. Urol Oncol. 2021. PMID: 33865687
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series.
Stabile A, Barletta F, Motterle G, Pellegrino F, Sorce G, Mazzone E, Scuderi S, Cirulli GO, Cucchiara V, Esposito A, Gandaglia G, Fossati N, De Cobelli F, Montorsi F, Karnes RJ, Briganti A. Stabile A, et al. Among authors: cirulli go. Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1137-1142. doi: 10.1038/s41391-021-00371-y. Epub 2021 May 3. Prostate Cancer Prostatic Dis. 2021. PMID: 33941867
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series.
Barletta F, Stabile A, Mazzone E, Brembilla G, Sorce G, Pellegrino F, Scuderi S, Cannoletta D, Cirulli GO, Cucchiara V, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Barletta F, et al. Among authors: cirulli go. Urol Oncol. 2022 Mar;40(3):103.e17-103.e24. doi: 10.1016/j.urolonc.2021.09.015. Epub 2021 Oct 27. Urol Oncol. 2022. PMID: 34688534
Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy Among Patients With Adverse Pathology at Radical Prostatectomy.
Mazzone E, Gandaglia G, Stabile A, Bravi CA, Barletta F, Scuderi S, Cirulli GO, Fossati N, Cucchiara V, Raggi D, Necchi A, Montorsi F, Briganti A. Mazzone E, et al. Among authors: cirulli go. J Urol. 2022 Nov;208(5):1046-1055. doi: 10.1097/JU.0000000000002855. Epub 2022 Jul 5. J Urol. 2022. PMID: 35830554
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database.
Barletta F, Mazzone E, Stabile A, Scuderi S, Brembilla G, de Angelis M, Cirulli GO, Cucchiara V, Gandaglia G, Karnes RJ, Roupret M, De Cobelli F, Montorsi F, Briganti A. Barletta F, et al. Among authors: cirulli go. World J Urol. 2022 Nov;40(11):2683-2688. doi: 10.1007/s00345-022-04155-4. Epub 2022 Sep 23. World J Urol. 2022. PMID: 36149448
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion?
Stabile A, Sorce G, Barletta F, Brembilla G, Mazzone E, Pellegrino F, Cannoletta D, Cirulli GO, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Stabile A, et al. Among authors: cirulli go. World J Urol. 2023 Nov;41(11):3231-3237. doi: 10.1007/s00345-023-04365-4. Epub 2023 Mar 21. World J Urol. 2023. PMID: 36943477
Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution Series.
Leni R, Gandaglia G, Stabile A, Mazzone E, Pellegrino F, Scuderi S, Robesti D, Barletta F, Cirulli GO, Cucchiara V, Zaffuto E, Dehò F, Montorsi F, Briganti A. Leni R, et al. Among authors: cirulli go. Eur Urol Oncol. 2023 Oct;6(5):493-500. doi: 10.1016/j.euo.2023.02.014. Epub 2023 Mar 31. Eur Urol Oncol. 2023. PMID: 37005213
23 results